These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2307186)

  • 1. Experimental observations on the pathogenesis of necrobacillosis.
    Smith GR; Wallace LM; Noakes DE
    Epidemiol Infect; 1990 Feb; 104(1):73-8. PubMed ID: 2307186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the infectivity of Fusobacterium necrophorum by other bacteria.
    Smith GR; Till D; Wallace LM; Noakes DE
    Epidemiol Infect; 1989 Jun; 102(3):447-58. PubMed ID: 2661253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive method for isolating Fusobacterium necrophorum from faeces.
    Smith GR; Barton SA; Wallace LM
    Epidemiol Infect; 1991 Apr; 106(2):311-7. PubMed ID: 2019300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity of Fusobacterium necrophorum biovar B.
    Smith GR
    Res Vet Sci; 1992 Mar; 52(2):260-1. PubMed ID: 1585082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of Fusobacterium necrophorum biovar A in animal faeces.
    Smith GR; Thornton EA
    Epidemiol Infect; 1993 Apr; 110(2):327-31. PubMed ID: 8472776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity of Fusobacterium necrophorum strains from man and animals.
    Smith GR; Thornton EA
    Epidemiol Infect; 1993 Jun; 110(3):499-506. PubMed ID: 8519315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of wallabies to Fusobacterium necrophorum.
    Smith GR; Turner A; Cinderey R
    Vet Rec; 1986 Jun; 118(25):691-3. PubMed ID: 3739178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrobacillosis and immunity in mice.
    Smith GR; Wallace LM; Till D
    Epidemiol Infect; 1989 Aug; 103(1):211-5. PubMed ID: 2673823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further observations on enhancement of the infectivity of Fusobacterium necrophorum by other bacteria.
    Smith GR; Barton SA; Wallace LM
    Epidemiol Infect; 1991 Apr; 106(2):305-10. PubMed ID: 1902184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of disturbance of the gastrointestinal microflora on the faecal excretion of Fusobacterium necrophorum biovar A.
    Smith GR; Thornton EA
    Epidemiol Infect; 1993 Apr; 110(2):333-7. PubMed ID: 8472777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of human and animal strains of Fusobacterium necrophorum by their pathogenic effects in mice.
    Smith GR; Thornton EA
    J Med Microbiol; 1997 Oct; 46(10):879-82. PubMed ID: 9364145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adverse effect of dilution on the infectivity of Fusobacterium necrophorum culture.
    Smith GR; Turner A
    J Hyg (Lond); 1986 Apr; 96(2):199-203. PubMed ID: 3517155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The weak immunogenicity of Fusobacterium necrophorum.
    Smith GR; Turner A; Murray LG; Oliphant JC
    J Hyg (Lond); 1985 Aug; 95(1):59-68. PubMed ID: 3894509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The two major subspecies of Fusobacterium necrophorum have distinct leukotoxin operon promoter regions.
    Zhang F; Nagaraja TG; George D; Stewart GC
    Vet Microbiol; 2006 Jan; 112(1):73-8. PubMed ID: 16303263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aetiological agents of necrobacillosis in captive wallabies.
    Oliphant JC; Parsons R; Smith GR
    Res Vet Sci; 1984 May; 36(3):382-4. PubMed ID: 6463385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the treatment of necrobacillosis in wallabies.
    Lewis JC; Fitzgerald AJ; Gulland FM; Hawkey CM; Kertesz P; Kirkwood JK; Kock RA
    Br Vet J; 1989; 145(4):394-6. PubMed ID: 2775989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrobacillosis: A case report of complicated Fusobacterium necrophorum septicemia.
    Darling MJ; Bryant SD; Kunz AN; Weisse ME
    Anaerobe; 2010 Apr; 16(2):171-3. PubMed ID: 19501182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necrobacillosis in humans.
    Dahlén G; Ebenfelt A
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):227-36. PubMed ID: 21342070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between leukocidin production and virulence of two isolates of Fusobacterium necrophorum.
    Coyle-Dennis JE; Lauerman LH
    Am J Vet Res; 1979 Feb; 40(2):274-6. PubMed ID: 464365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human necrobacillosis, with emphasis on Lemierre's syndrome.
    Hagelskjaer Kristensen L; Prag J
    Clin Infect Dis; 2000 Aug; 31(2):524-32. PubMed ID: 10987717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.